Latest Breaking News On - Commercial europe - Page 1 : comparemela.com

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S A

Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S A
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyMark marmurPatrick holtChristos papadopoulosAmarin corporationWorld health organizationExchange commissionGreek ministry of healthGreek ministrySenior vice presidentCommercial europeManufacturing plantsWorld healthGreek pharmaceuticalPrivate securities litigation reform act

Biocon Biologics Ltd : Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe

Biocon Biologics Ltd : Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCzech republicBiocon biologicsStefan klotterShreehas tambePrnewswire biocon biologics ltdBiocon biologics ltdBiocon ltdUn sustainable development goals sdgsBiocon biologics ltd in europeBiologics ltdNorth americaInsulin aspartInsulin glargineCommercial europe

Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe

Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. BENGALURU, India, Nov. 30, 2023 (GLOBE NEWSWIRE) Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business in 31 European countries has been successfully completed. Following the acquisitio

United kingdomCzech republicUnited statesStephanie wascoBiocon biologicsSaurabh paliwalShreehas tambeSeema ahujaBiocon biologics ltdUn sustainable development goals sdgsBiocon ltdBiocon biologics ltd in europeHead of communicationsBiologics ltdNorth americaInsulin aspart

Biocon Biologics Successfully Completes Integration of Viatris Biosimilar Business in 31 Countries in Europe

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris' biosimilars business in 31 European countries has been successfully completed.

United kingdomUnited statesCzech republicBiocon biologicsShreehas tambeBiocon biologics ltd in europeBiocon ltdUn sustainable development goals sdgsBiocon biologics ltdNorth americaInsulin aspartInsulin glargineCommercial europeBiocon biologics limitedDevelopment goalsGeneric formulations

SS Innovations Appoints Colin Eke to Lead Global Business Development

Mr. Eke brings more than 20 years’ industry experience to the role, including time spent at Intuitive Surgical and CMR Surgical FORT LAUDERDALE, FL, Oct. 06, 2023 via NewMediaWire - SS.

United kingdomSudhir srivastavaSurgical ltdDrug administrationGlobenewswire incSs innovations internationalSs innovations international incCe medical omnitivity ltdGlobal business developmentRobotic cardiac surgical programIntuitive surgicalSenior vice presidentGlobal businessChief executive officerGlobal headNew business